Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
best news of the day | TrendTrade2016 | investorshub | 04/25/2023 1:51:07 PM |
$IKT The now | conix | investorshub | 04/25/2023 7:09:07 AM |
Looks pretty positive | conix | investorshub | 04/25/2023 6:38:14 AM |
$IKT MomentumIts gaining | ProfitScout | investorshub | 04/24/2023 11:11:31 PM |
Price now | conix | investorshub | 04/24/2023 11:10:52 PM |
$IKT Looks pretty positive | conix | investorshub | 04/24/2023 10:59:09 PM |
$IKT When is this gonna take off? | PennyPusher786 | investorshub | 04/24/2023 3:30:09 PM |
$IKT just the news we needed | conix | investorshub | 04/24/2023 12:59:36 AM |
$IKT The now up | conix | investorshub | 04/23/2023 6:43:25 PM |
$IKT The trading up | conix | investorshub | 04/23/2023 3:58:44 PM |
news all the way baby | conix | investorshub | 04/23/2023 3:46:10 PM |
Price trading | conix | investorshub | 04/23/2023 3:02:38 PM |
$IKT Anyone hear anything lately? Want to see this one go | jedijazz | investorshub | 04/23/2023 5:43:44 AM |
$IKT Lets go go go go... Up up and away we go. | budfoxfun | investorshub | 04/22/2023 9:40:31 PM |
$IKT The gaining | PennyPusher786 | investorshub | 04/22/2023 7:01:46 PM |
$IKT short squeeze | budfoxfun | investorshub | 04/22/2023 5:05:56 PM |
Price trading last up | conix | investorshub | 04/22/2023 3:04:14 PM |
The trading | heyitsmeagain | investorshub | 04/22/2023 2:04:03 PM |
$IKT MomentumIts trading | jedijazz | investorshub | 04/22/2023 9:05:16 AM |
$IKT we got news | heyitsmeagain | investorshub | 04/22/2023 5:59:03 AM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...
BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or ...